News & Articles

xMAP SARS-CoV-2 Multi-Antigen IgG Assay is enabled by xMAP Technology, the gold standard for multiplexing serologic testing

The partnership aims to bring access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline

Patented PrimeStore MTM technology is designed to enable safe sample handling and testing for multiple pathogens from one sample swab

Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine

The strategic partnership aims to catapult COVID-19 diagnostic testing capacity well ahead of the significant demand

This is the company's third diagnostic test to receive Emergency Use Authorization by U.S. FDA for detecting COVID-19

Dr. Dennis Nurjadi discusses the cell counting technology that has brought his team accuracy and reproducibility

Join us on Monday, July 20, to discover the benefits of in-solution equilibrium affinity experiments using Gyrolab systems

Starts Monday, July 6. Register for free today to stay informed on the latest techniques and technologies for COVID-19 and infectious disease research

A study of COVID-19 in the quarantined Italian town of Vò, where most of the population was tested, reveals the importance of asymptomatic cases

Dr. Hanna Dreja explains the integral role of KO cell lines in ensuring confidence in results and quality control

Only IgG assay from top four in vitro diagnostic manufacturers that detects antibodies targeting the receptor binding domain on the spike protein

Providing researchers with expanded capabilities in interrogating the tissue microenvironment

Download this application note from Sartorius to discover how the need to monitor T cell phenotype and function for improved T cell expansion protocols was addressed with a T cell memory cell and cytokine profiling assay

Join us on Thursday, 9 July, to learn how Abcam applies KO validation at a large scale and the lessons learned from implementing this initiative

Researchers are to assess the effectiveness of tests that may give doctors COVID-19 results in minutes rather than days

Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays

Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier

Join this webinar to find out how scientists are detecting the antibodies blocking viral entry into the cell

New research assesses the interaction between the SARS-CoV-2 Spike S1 protein receptor binding domain (SARS-CoV-2 S1 RBD) and heparin